IDXX vs VNO · P/E 40, rev $2.36B vs rev $921.3M
IDEXX Laboratories Inc (IDXX) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
VNO (VNO) common stock.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. VNO currently screens at market cap $0.
Not investment advice. Open the IDXX and VNO stock pages for the full models.
Not investment advice.